Biosynthetic Technologies
About Biosynthetic Technologies
Biosynthetic Technologies is a company based in Indianapolis (United States) founded in 2012 was acquired by Calumet Specialty Products Partners in April 2018.. Biosynthetic Technologies has raised $52.24 million across 8 funding rounds from investors including bp, Monsanto and The Heritage Group. Biosynthetic Technologies has completed 1 acquisition, including Innoleo. Biosynthetic Technologies offers products and services including Estolides, BioEstolides, and Industrial Lubricants. Biosynthetic Technologies operates in a competitive market with competitors including GSK, Avidity Biosciences, Sutro Biopharma, Antheia and Vividion Therapeutics, among others.
- Headquarter Indianapolis, United States
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Biosynthetic Technologies, Llc
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$52.24 M (USD)
in 8 rounds
-
Latest Funding Round
$9.5 M (USD), Series A
May 07, 2019
-
Investors
bp
& 5 more
-
Employee Count
Employee Count
- Investments & Acquisitions
-
Acquired by
Calumet Specialty Products Partners
(Apr 09, 2018)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Biosynthetic Technologies
Biosynthetic Technologies offers a comprehensive portfolio of products and services, including Estolides, BioEstolides, and Industrial Lubricants. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Sustainable compounds from bio-derived fatty acids for lubricant formulations.
Biodegradable oils for skincare and cosmetics applications.
High-performance oils for gear and hydraulic systems.
Unlock access to complete
Funding Insights of Biosynthetic Technologies
Biosynthetic Technologies has successfully raised a total of $52.24M across 8 strategic funding rounds. The most recent funding activity was a Series A round of $9.5 million completed in May 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 8
- Last Round Series A — $9.5M
-
First Round
First Round
(03 Aug 2012)
- Investors Count 5
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May, 2019 | Amount | Series A - Biosynthetic Technologies | Valuation | The Heritage Group |
|
| Feb, 2017 | Amount | Debt – Conventional - Biosynthetic Technologies | Valuation |
investors |
|
| Oct, 2014 | Amount | Series A - Biosynthetic Technologies | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Biosynthetic Technologies
Biosynthetic Technologies has secured backing from 6 investors, including venture fund and institutional investors. Prominent investors backing the company include bp, Monsanto and The Heritage Group. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
A family-owned business managing diverse industrial and environmental companies.
|
Founded Year | Domain | Location | |
|
Corporate venture capital investments are made by Evonik.
|
Founded Year | Domain | Location | |
|
bp is recognized as a global energy company.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Biosynthetic Technologies
Biosynthetic Technologies has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Innoleo. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Supplier & distributor of castor oil and derivatives of castor oil
|
2011 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Biosynthetic Technologies
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Biosynthetic Technologies Comparisons
Competitors of Biosynthetic Technologies
Biosynthetic Technologies operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GSK, Avidity Biosciences, Sutro Biopharma, Antheia and Vividion Therapeutics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of pharmaceuticals and vaccines for various therapeutic areas
|
|
| domain | founded_year | HQ Location |
Antibody-siRNA complexes are developed for cancer treatment.
|
|
| domain | founded_year | HQ Location |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
|
|
| domain | founded_year | HQ Location |
Yeast cells are genetically engineered to produce medicinal products.
|
|
| domain | founded_year | HQ Location |
Developing novel drugs based on a proteome-wide ligand and target discovery platform
|
|
| domain | founded_year | HQ Location |
CRISPR-engineered cell and gene therapies are developed for research applications.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Biosynthetic Technologies
Frequently Asked Questions about Biosynthetic Technologies
When was Biosynthetic Technologies founded?
Biosynthetic Technologies was founded in 2012.
Where is Biosynthetic Technologies located?
Biosynthetic Technologies is headquartered in Indianapolis, United States. It is registered at Indianapolis, Indiana, United States.
Who is the current CEO of Biosynthetic Technologies?
Mark Miller is the current CEO of Biosynthetic Technologies.
Is Biosynthetic Technologies a funded company?
Biosynthetic Technologies is a funded company, having raised a total of $52.24M across 8 funding rounds to date. The company's 1st funding round was a Series A of $12M, raised on Aug 03, 2012.
What does Biosynthetic Technologies do?
Manufacturer of bio-based green oils. They produce synthetic oils, called estolides, from organic fatty acids found in various bio-derived oils. These are bio-degradable non-toxic and can be used as the primary base oil of a lubricant formulation, a component of a base oil co-blend, or as an additive. These oils have applications in many industries, such as cosmetic, chemicals, food-grade lubricants, car motor oil, and marine lubricant.
Who are the top competitors of Biosynthetic Technologies?
Biosynthetic Technologies's top competitors include Sutro Biopharma, Synthego and Avidity Biosciences.
What products or services does Biosynthetic Technologies offer?
Biosynthetic Technologies offers Estolides, BioEstolides, and Industrial Lubricants.
How many acquisitions has Biosynthetic Technologies made?
Biosynthetic Technologies has made 1 acquisition, including Innoleo.
Who are Biosynthetic Technologies's investors?
Biosynthetic Technologies has 6 investors. Key investors include bp, Monsanto, The Heritage Group, Evonik Venture Capital, and OSTI.GOV.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.